Abstract：Objective: To investigate the effect of DT-3, a specific inhibitor of the PKGIα signaling pathway, on the proliferation and migration of gastric cancer cells. Methods: Bioinformatics analysis was used to analyze the differential expression of PKGI in tissues and explore the prognosis of PKGI and PKGIα in gastric cancer patients based on the GEO, TCGA, HPA, Kaplan-Meier plotter databases and GEPIA online analysis website. CCK-8 and colony formation assays were used to detect the effect of DT-3 on cell proliferation, and wound healing assay was used to observe the effect of DT-3 on cell migration. Western blotting was used to verify the protein expression of PKGIα and correlation analysis was performed. Results: The expression of PKGI mRNA was increased in gastric adenocarcinoma tissues, and 27 out of 42 gastric cancer cell lines expressed PKGI mRNA. Gastric cancer tissues with high expression of PKGIα mRNA were more aggressive. Immunohistochemical (IHC) results showed that 6 out of 12 gastric cancer tissues showed moderate to strong cytoplasmic positive staining reaction. The expression of PKGI was negatively correlated with CDH1 (r=-0.74, P<0.05). Survival analysis showed that high expression of PKGI and PKGIα mRNA was significantly associated with overall survival (OS) of gastric adenocarcinoma patients (HR>1, logrank P<0.05). The experimental results showed that the expression of PKGIα protein was increased in human gastric cancer cell line AGS. DT-3 inhibited cell proliferation and migration (P<0.05), decreased the expression of phosphorylated p65 of NF-κB, and the expression of PKGI and NF-κB p-p65 was extremely positively correlated (r=0.957, P<0.05). Conclusion: Inhibition of the PKGIα signaling pathway by DT-3 can effectively inhibit the proliferation and migration of gastric cancer cells.
张秀芬, 潘理会, 李春辉. PKGIα通路抑制剂DT-3对胃癌细胞增殖和迁移的影响[J]. 河北医学, 2024, 30(4): 555-560.
ZHANG Xiufen, et al. Signaling Pathway by DT-3 a Inhibitor of the PKGIα Pathway on Proliferation and Migration of Gastric Cancer Cells. HeBei Med, 2024, 30(4): 555-560.
[1] 郑荣寿,张思维,孙可欣,等.2016年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2023,45(3):212-220. [2] Pang J,Li G,Qian H,et al.Secretory type Ⅱ cGMP-dependent protein kinase blocks activation of PDGFRβ via Ser254 in gastric cancer cells[J].Cell Biol Int,2022,46(5):747-754. [3] Soltek S,Karakhanova S,Golovastova M,et al.Anti-tumor properties of the cGMP/protein kinase G inhibitor DT3 in pancreatic adenocarcinoma[J].Naunyn Schmiedebergs Arch Pharmacol,2015,388(11):1121-1128. [4] Motolani A,Martin M,Sun M,et al.Phosphorylation of the regulators,a complex facet of NF-κB signaling in cancer[J].Biomolecules,2020,11(1):15. [5] Wang Y,Su J,Wang Y,et al.The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis[J].Exp Clin Cancer Res,2019,38(1):386. [6] Hutter C,Zenklusen JC.The cancer genome atlas:creating lasting value beyond its data[J].Cell,2018,173(2):283-285. [7] Lanczky A,Gyorffy B.Web-based survival analysis tool tailored for medical research (KMplot):development and implementation[J].Med Internet Res,2021,23(7):e27633. [8] Li C,Tang Z,Zhang W,et al.GEPIA2021:integrating multiple deconvolution-based analysis into GEPIA[J].Nucleic Acids Res,2021,49(W1):242-246. [9] Hu K,Zheng QM,Wang YP,et al.Clinical and prognostic features of E-cadherin in adenocarcinoma of the esophagogastric junction patients[J].Eur Cancer Prev,2023,32(2):119-125. [10] 谭林,王骞,屈伟明,等.胃癌组织中幽门螺杆菌感染和p-p65、EMT相关蛋白的表达及临床意义[J].现代消化及介入诊疗,2019,24(11):1245-1251. [11] 朱亚清,李春辉,何涛,等.ANP对胃癌MGC-803细胞增殖迁移的影响及机制的研究[J].河北医学,2020,26(12):1943-1947.
2024, Vol. 30 
冀公网安备13080202000786号